FARx Group
PrivateLast Round
Grant
Oct 1, 2025
Est. Valuation
$5.69M
Total Funding Raised
$354,500
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FARx Group operates in Healthcare & Life Sciences and is based in the United Kingdom. Its latest recorded funding round was a Grant round in October 2025.
FARx Group is a cybersecurity company that develops an AI-powered, fused voice and face biometric recognition platform designed to provide continuous, multi-factor identity verification and deepfake detection.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Supply Chain, Logistics Software, Supply Chain Tracking
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FARx Group Comparables
Compare FARx Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ValidSoft | 80% | |
| Wink | 76% | |
| Veridas | 74% |
For institutional investors. Book with your work email.
FARx Group Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
FARx Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seed Enterprise Investment Scheme | Seed |
| Innovation Worcestershire | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 41% MoM, reaching 1.8K.
- Jul 25, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 8, 2026
FARx Group appoints Clive Busby as Vice President of Sales and Marketing earlier in 2026, strengthening its leadership team.
- receives_financingSep 8, 2026
FARx Group receives $846K in Seed financing on Sep 8th '26 to expand its AI-powered biometric authentication technology into global markets.
- hiresSep 8, 2026
On Sep 8th '26, FARx Group appoints Chris Bruce as Chairman to support its next phase of UK and international growth after securing £625,000 in seed funding in the United Kingdom.
For institutional investors. Book with your work email.
FARx Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FARx Group's valuation, stock price, and market status.
Is FARx Group a public or private company?
FARx Group is a private company.
What is the current stock price of FARx Group?
FARx Group is a private company, so its shares have no public market price. Caplight tracks FARx Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FARx Group worth (valuation)?
FARx Group's valuation is estimated at $5.7M based on funding round data.
Can I buy FARx Group stock?
FARx Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FARx Group's last funding round?
FARx Group's most recent funding round was Grant on October 1, 2025.
Who are the main investors in FARx Group?
Key investors in FARx Group include Seed Enterprise Investment Scheme, Innovation Worcestershire.
Will FARx Group IPO soon?
No public IPO plans have been announced for FARx Group.
How can I track FARx Group secondary market activity?
Caplight tracks bids, offers, and trades in FARx Group's shares on secondary markets.